Nuon Therapeutics, Inc. - Product Pipeline Review - 2012

Global Markets Direct, July 2012, Pages: 32

Nuon Therapeutics, Inc. – Product Pipeline Review – 2012

Summary

Global Market Direct’s pharmaceuticals report, “Nuon Therapeutics, Inc. - Product Pipeline Review - 2012” provides data on the Nuon Therapeutics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Nuon Therapeutics, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Nuon Therapeutics, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Nuon Therapeutics, Inc. - Brief Nuon Therapeutics, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Nuon Therapeutics, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Nuon Therapeutics, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Nuon Therapeutics, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Nuon Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Nuon Therapeutics, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Nuon Therapeutics, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Nuon Therapeutics, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Nuon Therapeutics, Inc. and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Nuon Therapeutics, Inc.; Nuon Therapeutics, Inc. - Key Therapeutics; Nuon Therapeutics, Inc. - Pipeline Overview and Promising Molecules; Nuon Therapeutics, Inc. - News; Nuon Therapeutics, Inc. - Latest Updates; Nuon Therapeutics, Inc. - Pipeline; Nuon Therapeutics, Inc. - Discontinued/Dormant Projects

2
List of Tables 3
List of Figures 4
Nuon Therapeutics, Inc. Snapshot 5
Nuon Therapeutics, Inc. Overview 5
Key Information 5
Key Facts 5
Nuon Therapeutics, Inc. – Research and Development Overview 6
Key Therapeutic Areas 6
Nuon Therapeutics, Inc. – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
Pipeline Products – Combination Treatment Modalities 10
Nuon Therapeutics, Inc. – Pipeline Products Glance 11
Nuon Therapeutics, Inc. Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Nuon Therapeutics, Inc. – Early Stage Pipeline Products 12
Pre-Clinical Products/Combination Treatment Modalities 12
Nuon Therapeutics, Inc. – Drug Profiles 13
Drug For Other Autoimmune Diseases 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
NU1618 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Rizaben 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Rizaben + Uloric 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Nuon Therapeutics, Inc. – Pipeline Analysis 18
Nuon Therapeutics, Inc. – Pipeline Products by Therapeutic Class 18
Nuon Therapeutics, Inc. – Pipeline Products By Target 19
Nuon Therapeutics, Inc. – Pipeline Products by Route of Administration 20
Nuon Therapeutics, Inc. – Pipeline Products By Mechanism of Action 21
Nuon Therapeutics, Inc. – Recent Pipeline Updates 22
Nuon Therapeutics, Inc. – Locations And Subsidiaries 23
Head Office 23
Financial Deals Landscape 24
Nuon Therapeutics, Inc., Deals Summary 24
Nuon Therapeutics, Inc., Pharmaceuticals & Healthcare, Deal Details 25
Venture Financing 25
Nuon Therapeutics Secures $10 Million In Venture Financing 25
Nuon Therapeutics Secures $6.05 Million In Venture Financing 26
Nuon Therapeutics Secures $27 Million In Series B Financing 27
Nuon Therapeutics Secures $5 Million In Series A Financing 29
Licensing Agreements 30
Kissei Pharma Enters Into Licensing, Supply And Collaboration Agreement With Nuon Therapeutics 30
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 32
Disclaimer 32

List of Tables
Nuon Therapeutics, Inc., Key Information 5
Nuon Therapeutics, Inc., Key Facts 5
Nuon Therapeutics, Inc. – Pipeline by Indication, 2012 7
Nuon Therapeutics, Inc. – Pipeline by Stage of Development, 2012 8
Nuon Therapeutics, Inc. – Monotherapy Products in Pipeline, 2012 9
Nuon Therapeutics, Inc. – Combination Treatment Modalities in Pipeline, 2012 10
Nuon Therapeutics, Inc. – Phase II, 2012 11
Nuon Therapeutics, Inc. – Pre-Clinical, 2012 12
Nuon Therapeutics, Inc. – Pipeline By Therapeutic Class, 2012 18
Nuon Therapeutics, Inc. - Pipeline By Target, 2012 19
Nuon Therapeutics, Inc. – Pipeline By Route of Administration, 2012 20
Nuon Therapeutics, Inc. – Pipeline Products By Mechanism of Action, 2012 21
Nuon Therapeutics, Inc. – Recent Pipeline Updates, 2012 22
Nuon Therapeutics, Inc., Deals Summary 24
Nuon Therapeutics Secures $10 Million In Venture Financing 25
Nuon Therapeutics Secures $6.05 Million In Venture Financing 26
Nuon Therapeutics Secures $27 Million In Series B Financing 27
Nuon Therapeutics Secures $5 Million In Series A Financing 29
Kissei Pharma Enters Into Licensing, Supply And Collaboration Agreement With Nuon Therapeutics 30

List of Figures
Nuon Therapeutics, Inc. – Pipeline by Indication, 2012 7
Nuon Therapeutics, Inc. – Pipeline by Stage of Development, 2012 8
Nuon Therapeutics, Inc. – Monotherapy Products in Pipeline, 2012 9
Nuon Therapeutics, Inc. – Combination Treatment Modalities in Pipeline, 2012 10
Nuon Therapeutics, Inc. – Pipeline By Therapeutic Class, 2012 18
Nuon Therapeutics, Inc. - Pipeline By Target, 2012 19

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Scientific Games Corporation - Company Analysis
• eBay - Strong Execution
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Ixia - Company Analysis
• Amazon - Point of Realization in 2013?
• SunGard - Profile - US
• CIBER Inc
• Dell Inc.